Christopher Dodds V sold $756k of SCHW
director at SCHWAB CHARLES CORP. 9,284 shares at an average of $81.43, traded Nov 18, 2024, filed Nov 20, 2024.
Score components
- +15RoleDirector
- +22Trade size$756k at market
- 0Share of holdings soldSold 2.1% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001186004-24-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 18, 2024 | MOption exercise Common Stock | +4,992 | $33.40 | $167k | 9,204 | Nov 20, 2024 |
| Nov 18, 2024 | MOption exercise Common Stock | +4,292 | $43.21 | $185k | 9,204 | Nov 20, 2024 |
| Nov 18, 2024 | SOpen-market sale Common Stockindirect: by Trust | -9,284 | $81.43 | $756k | 442,807 | Nov 20, 2024 |
| Nov 18, 2024 | MOption exercise Nonqualified Stock Option (right to buy)derivative | +4,992 | $0.00 | $0 | 0 | Nov 20, 2024 |
| Nov 18, 2024 | MOption exercise Nonqualified Stock Option (right to buy)derivative | +4,292 | $0.00 | $0 | 0 | Nov 20, 2024 |
Related signals
Other insiders at SCHWAB CHARLES CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | SCHWAB CHARLES CORP | Neesha Hathi MD, Head Wealth Adv, Bnk, Tst | $489k 5,000 shares | -46% | |
| 5Weak | SCHWAB CHARLES CORP | Neesha Hathi MD, Head Wealth Adv, Bnk, Tst | $346k 3,177 shares | -36% | |
| 40Moderate | SCHWAB CHARLES CORP | Jonathan M. Craig MD, Head of Investor Services | $1.8M 23,258 shares | -100% | |
| 25Weak | SCHWAB CHARLES CORP | Jonathan M. Craig MD, Head of Investor Services | $2.3M 28,668 shares | -55% | |
| 40Moderate | SCHWsell SCHWAB CHARLES CORP | Walter W Bettinger Co-Chairman | $38M 464,629 shares | -36% | |
| 16Weak | SCHWAB CHARLES CORP | Carolyn Schwab-Pomerantz director | $714k 9,000 shares | -1% | |
| 12Weak | SCHWAB CHARLES CORP | Jonathan S Beatty MD, Head of Advisor Services | $189k 2,300 shares | -11% | |
| 60Notable | SCHWAB CHARLES CORP | Nigel J Murtagh Chief Risk Officer | $1.0M 12,739 shares | -18% | |
| 31Weak | SCHWAB CHARLES CORP | Carolyn Schwab-Pomerantz director | $720k 9,000 shares | -1% | |
| 12Weak | SCHWAB CHARLES CORP | Jonathan S Beatty MD, Head of Advisor Services | $221k 2,700 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.